Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-211At-astato-ben...
Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-211At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing
About this item
Full title
Author / Creator
Publisher
Sydney: Ivyspring International Publisher
Journal title
Language
English
Formats
Publication information
Publisher
Sydney: Ivyspring International Publisher
Subjects
More information
Scope and Contents
Contents
Targeted α-particle therapy is a promising option for patients with malignant pheochromocytoma. Recent observations regarding
meta
-
211
At-astato-benzylguanidine (
211
At-MABG) in a pheochromocytoma mouse model showed a strong anti-tumor effect, though the molecular mechanism remains elusive. Here, we present the first comprehens...
Alternative Titles
Full title
Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-211At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6485192
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6485192
Other Identifiers
E-ISSN
1838-7640
DOI
10.7150/thno.30353
